(Q34390189)

1 August 2017

1 reference

title

Current status of antiretroviral therapies (English)

1 reference

1 August 2017

anti-retroviral agent

0 references

author name string

Temesgen Z

series ordinal

1

1 reference

PubMed ID

11584991

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Expert Opinion on Pharmacotherapy

1 August 2017

1 reference

1 August 2017

2

1 reference

1 August 2017

8

1 reference

1 August 2017

1239-1246

1 reference

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.8.1239

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.8.1239

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.8.1239

Management protocol for abacavir-related hypersensitivity reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.8.1239

"Buffalo hump" in men with HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.8.1239

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.8.1239

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.8.1239

10.1517/14656566.2.8.1239

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11584991